A 29-year-old man with a history of cerebellar stroke was referred due to refractory hypertension. His blood pressure was 162/91 mmHg even with doxazosin, nifedipine and cilnidipine. Urinary excretions of catecholamines (adrenaline, 59.1 μg/day; noradrenaline, 1,043.9 μg/day) were elevated. No tumor was detected in the adrenal gland by computed tomography ([Picture A](#g001){ref-type="fig"}, arrowhead) or magnetic resonance imaging ([Picture B](#g001){ref-type="fig"}, arrow). However, ^123^I-metaiodobenzylguanidine (MIBG) single-photon emission computed tomography (SPECT) revealed the specific uptake in the bilateral adrenal glands with a tumor/liver (T/L) ratio of 1.83 in the left and 2.10 in the right ([Picture C, D](#g001){ref-type="fig"}), findings suggestive of adrenomedullary hyperplasia (AMH). Clonidine failed to reduce the plasma catecholamine levels. AMH is basically stable under α-blocker treatment but is considered to be a preclinical condition of pheochromocytoma ([@B1]). Due to the high sensitivity of ^123^I-MIBG SPECT, we were able to detect false-positive AMH; however, combining imaging findings with the T/L ratio may improve the diagnostic performance ([@B2]). AMH should be considered as a differential diagnosis of refractory juvenile hypertension.
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